…DTx protocols enabled by the MindPod are the subject of many ongoing trials worldwide for indications such as stroke, Parkinson’s disease, dementia and healthy ageing, underscoring its potential for more…
Content Section: News Posts
…can cause AHS, but additionally causes parkinsonism, apraxia, aphasia, and dementia [5]. This diagnosis was ruled out as it is also characterised by an insidious onset and progressive course. Our…
Content Section: Case Reports
…Neurology Traumatic brain injury – David Sharp, NIHR Professor & Consultant Neurologist, The Computational, Cognitive and Clinical Neuroimaging Laboratory (C3NL), Imperial College Londo Dementia i & ii – Adam Zeman,…
Content Section: Event News
…from name in semantic dementia provides evidence for graded, transmodal semantic knowledge Our afternoon theme of neuromodulation commenced with a joint session with the American Neuropsychiatric Association, in which Dr…
Content Section: Conference Reports
…(Clinical Dementia Rating Sum of Boxes), the global cognitive and functional scale, and key secondary endpoints were the change from baseline at 18 months in amyloid Positron Emission Tomography (PET)…
Content Section: News Posts
…the biopsychosocial framework within developmental context. Professor Espay explored the connection between FND and Parkinson’s Disease (PD), suggesting a presence of functional manifestations for people with PD and dementia. Professor…
Content Section: Conference Reports
…was published on April 10 2023 in the journal Alzheimer’s & Dementia. “We previously showed that people with European ancestry have higher APOE4 expression than their African counterparts, but we didn’t understand…
Content Section: News Posts
…AD and mild AD dementia) with confirmed amyloid pathology in the brain,1 to the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain. This investigational treatment has been designated…
Content Section: News Posts
…Company’s mission of developing potential first-in-class therapies targeting toxic fibrin accumulation for areas of significant unmet patient need,” said Laurence Barker, Partner, Dementia Discovery Fund (DDF). About Therini Bio, Inc….
Content Section: News Posts
© 2024 ACNR. Published by Whitehouse Publishing. Read our Privacy and Cookie Policy. Website by Sugar Web.
Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.
For UK-based specialists, sign up for our journal mailing list.
URL here
You are now leaving the ACNR website, please click the "Continue" button below. If you do not wish to leave, please close this pop-up.
